Loading clinical trials...
Loading clinical trials...
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ECOG-ACRIN Cancer Research Group
Collaborators
NCT06616155 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more
NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more
NCT04693377 · Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, and more
NCT06389786 · Localized Prostate Carcinoma, Oligometastatic Prostate Carcinoma, and more
NCT05398302 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, and more
Mayo Clinic Hospital in Arizona
Phoenix, Arizona
Mayo Clinic in Arizona
Scottsdale, Arizona
Yale University
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions